7SOL

Crystal Structures of the bispecific ubiquitin/FAT10 activating enzyme, Uba6


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.25 Å
  • R-Value Free: 0.206 
  • R-Value Work: 0.166 
  • R-Value Observed: 0.166 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 2.0 of the entry. See complete history


Literature

Crystal structures reveal catalytic and regulatory mechanisms of the dual-specificity ubiquitin/FAT10 E1 enzyme Uba6.

Yuan, L.Gao, F.Lv, Z.Nayak, D.Nayak, A.Santos Bury, P.D.Cano, K.E.Jia, L.Oleinik, N.Atilgan, F.C.Ogretmen, B.Williams, K.M.Davies, C.El Oualid, F.Wasmuth, E.V.Olsen, S.K.

(2022) Nat Commun 13: 4880-4880

  • DOI: https://doi.org/10.1038/s41467-022-32613-5
  • Primary Citation of Related Structures:  
    7SOL

  • PubMed Abstract: 

    The E1 enzyme Uba6 initiates signal transduction by activating ubiquitin and the ubiquitin-like protein FAT10 in a two-step process involving sequential catalysis of adenylation and thioester bond formation. To gain mechanistic insights into these processes, we determined the crystal structure of a human Uba6/ubiquitin complex. Two distinct architectures of the complex are observed: one in which Uba6 adopts an open conformation with the active site configured for catalysis of adenylation, and a second drastically different closed conformation in which the adenylation active site is disassembled and reconfigured for catalysis of thioester bond formation. Surprisingly, an inositol hexakisphosphate (InsP6) molecule binds to a previously unidentified allosteric site on Uba6. Our structural, biochemical, and biophysical data indicate that InsP6 allosterically inhibits Uba6 activity by altering interconversion of the open and closed conformations of Uba6 while also enhancing its stability. In addition to revealing the molecular mechanisms of catalysis by Uba6 and allosteric regulation of its activities, our structures provide a framework for developing Uba6-specific inhibitors and raise the possibility of allosteric regulation of other E1s by naturally occurring cellular metabolites.


  • Organizational Affiliation

    Department of Biochemistry & Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229, USA.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Ubiquitin-like modifier-activating enzyme 6
A, C
1,020Homo sapiensMutation(s): 1 
Gene Names: UBA6MOP4UBE1L2
EC: 6.2.1.45
UniProt & NIH Common Fund Data Resources
Find proteins for A0AVT1 (Homo sapiens)
Explore A0AVT1 
Go to UniProtKB:  A0AVT1
PHAROS:  A0AVT1
GTEx:  ENSG00000033178 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA0AVT1
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 2
MoleculeChains Sequence LengthOrganismDetailsImage
Ubiquitin
B, D
83Triticum aestivumMutation(s): 7 
UniProt
Find proteins for P69326 (Triticum aestivum)
Explore P69326 
Go to UniProtKB:  P69326
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP69326
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.25 Å
  • R-Value Free: 0.206 
  • R-Value Work: 0.166 
  • R-Value Observed: 0.166 
  • Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 248.572α = 90
b = 101.317β = 117.996
c = 122.921γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
HKL-2000data reduction
HKL-2000data scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesGM115568
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesGM128731
Cancer Prevention and Research Institute of Texas (CPRIT)United StatesRR200030

Revision History  (Full details and data files)

  • Version 1.0: 2022-11-02
    Type: Initial release
  • Version 1.1: 2023-05-03
    Changes: Database references, Refinement description
  • Version 1.2: 2023-10-25
    Changes: Data collection, Refinement description
  • Version 2.0: 2024-04-17
    Changes: Atomic model, Derived calculations